Experimental studies have suggested that disruption in the insulin signaling pathway in the brain may contribute to neuroinflammatory cascades involving inflammation, oxidative stress, and increased a-synuclein deposition in the brain, all of which serve to accelerate neuronal death and are associated with poorer prognosis in PD [43,44,45]. The gene discussed is INS; the disease is Parkinson disease.